James R. Gruber - 11 Apr 2022 Form 3 Insider Report for Eton Pharmaceuticals, Inc. (ETON)

Role
Chief Financial Officer
Signature
/s/ James Gruber
Issuer symbol
ETON
Transactions as of
11 Apr 2022
Net transactions value
$0
Form type
3
Filing time
14 Apr 2022, 16:05:28 UTC
Next filing
18 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ETON Employee Stock Options 11 Apr 2022 Common Stock 100,000 $3.81 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options awarded on April 11, 2022 to Reporting Person pursuant to the Company's 2018 Equity Incentive Plan (the "Plan"). The stock options vest contingent upon continued employment as follows: 25, 000 on April 11, 2023, 25,000 on April 11, 2024, 25,000 on April 11, 2025 and 25,000 on April 11, 2026.